IXICO Plc (IXI):企業の財務・戦略的SWOT分析

◆英語タイトル:IXICO Plc (IXI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14913
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to transfer data, web-based system to track imaging-based research study or clinical trial in real time, medical device for clinical diagnosis of dementia, and others. The company’s TrialTracker platform supports to provide superior data management and specialist analytics, and Assessa for clinical decision support. IXICO is headquartered in London, Greater London, the UK.

IXICO Plc Key Recent Developments

Mar 05,2019: IXICO continues to be first choice for imaging services in Huntington’s disease
Mar 01,2019: IXICO chosen as partner for new Government funded Medical Imaging & Artificial Intelligence Centre
Feb 07,2019: IXICO: Appointment of chief financial officer
Dec 11,2018: IXICO announces directorate change
Dec 04,2018: IXICO: Financial results for the year ended 30 September 2018

This comprehensive SWOT profile of IXICO Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of IXICO Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

IXICO Plc – Key Information
IXICO Plc – Overview
IXICO Plc – Key Employees
IXICO Plc – Key Employee Biographies
IXICO Plc – Key Operational Heads
IXICO Plc – Major Products and Services
IXICO Plc – History
IXICO Plc – Company Statement
IXICO Plc – Locations And Subsidiaries
IXICO Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

IXICO Plc – Business Description
IXICO Plc – Corporate Strategy
IXICO Plc – SWOT Analysis
SWOT Analysis – Overview
IXICO Plc – Strengths
IXICO Plc – Weaknesses
IXICO Plc – Opportunities
IXICO Plc – Threats
IXICO Plc – Key Competitors

Section 3 – Company Financial Performance Charts

IXICO Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

IXICO Plc, Key Information
IXICO Plc, Key Ratios
IXICO Plc, Share Data
IXICO Plc, Major Products and Services
IXICO Plc, History
IXICO Plc, Key Employees
IXICO Plc, Key Employee Biographies
IXICO Plc, Key Operational Heads
IXICO Plc, Other Locations
IXICO Plc, Subsidiaries
IXICO Plc, Key Manufacturing facilities
IXICO Plc, Key Competitors
IXICO Plc, SWOT Analysis
IXICO Plc, Ratios based on current share price
IXICO Plc, Annual Ratios
IXICO Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

IXICO Plc, Performance Chart
IXICO Plc, Ratio Charts

★海外企業調査レポート[IXICO Plc (IXI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • MSM Malaysia Holdings Berhad (MSM):企業の財務・戦略的SWOT分析
    MSM Malaysia Holdings Berhad (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務分析
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Societe Generale S.A.:戦略・SWOT・企業財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nissin Foods Holdings Co Ltd (2897):企業の財務・戦略的SWOT分析
    Nissin Foods Holdings Co Ltd (2897) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sligro Food Group NV:企業の戦略・SWOT・財務分析
    Sligro Food Group NV - Strategy, SWOT and Corporate Finance Report Summary Sligro Food Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • HealthEquity Inc (HQY):企業の財務・戦略的SWOT分析
    Summary HealthEquity Inc (HealthEquity) is a healthcare service provider that offers health savings management services. The company provides integrated health accounts such as health savings account, health reimbursement arrangements, flexible spending accounts for health plans, and health incentiv …
  • China Digital Culture (Group) Ltd (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Ltd (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM):企業の財務・戦略的SWOT分析
    Summary J B Chemicals and Pharmaceuticals Ltd (JBCPL) is a pharmaceutical company that manufactures and markets pharmaceutical formulations. The company provides products such as tablets, lozenges, injectables, creams, gels, ointments, liquid herbal syrups, capsules, and others. It provides contract …
  • BWX Technologies Inc (BWXT):電力:M&Aディール及び事業提携情報
    Summary BWX Technologies Inc (BWXT) is a specialty manufacturer of nuclear components. It designs, engineers, and manufactures precision naval nuclear components, reactors, and nuclear fuel for the US Government. The company also provides special nuclear materials processing and environmental site r …
  • Cardiac Dimensions Inc-医療機器分野:企業M&A・提携分析
    Summary Cardiac Dimensions Inc (Cardiac Dimensions) is a medical equipment provider that develops intervention tools used for treating heart failure and other related condition of mitral valve regurgitation. The company’s system uses a catheter based approach in order to reshape the mitral valve and …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • La Mancha Holding SaRL:企業の戦略・SWOT・財務情報
    La Mancha Holding SaRL - Strategy, SWOT and Corporate Finance Report Summary La Mancha Holding SaRL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …
  • J.B. Hunt Transport Services, Inc.:企業の戦略・SWOT・財務情報
    J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Weyerhaeuser Co (WY):企業の財務・戦略的SWOT分析
    Weyerhaeuser Co (WY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ClubCorp Holdings Inc:企業のM&A・事業提携・投資動向
    ClubCorp Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ClubCorp Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pharma Mar SA (PHM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • PT Bank China Construction Bank Indonesia Tbk:企業の戦略・SWOT・財務分析
    PT Bank China Construction Bank Indonesia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank China Construction Bank Indonesia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆